While NDE-P-181-tau levels have been shown to be elevated in people with Alzheimer's disease (11, 13), the existing evidence linking ADE-P-181-tau burden with cognition in PWS is limited. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.